NCT02371239 SIT LESS 2: Effect of Sitting Less on Glucose Regulation in People With Diabetes Mellitus Type 2 Status COMPLETED Phase NA
NCT02321878 Post-marketing Surveillance (Special Use-results Surveillance) on Use With Liraglutide (Victoza®) Status COMPLETED Phase N/A
NCT02306681 A Survey on Low Blod Sugar Among Insulin-treated Patients With Diabetes Status COMPLETED Phase N/A
NCT02305381 Efficacy and Safety of Semaglutide Once-weekly Versus Placebo as add-on to Basal Insulin Alone or Basal Insulin in Combination With Metformin in Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02304627 Effect of Food on the Pharmacokinetics of NNC0123-0000-0338 in a Tablet Formulation in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02300844 Investigation on Safety, Tolerability and Pharmacokinetics of Single Doses of NNC0174-0833 in Normal Weight, Overweight to Obese But Otherwise Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02299388 To Evaluate the Effect of Liraglutide on Ambulatory Blood Pressure-A Pilot Study Status COMPLETED Phase PHASE4
NCT02298192 A Clinical Trial Comparing Efficacy and Safety of Insulin Degludec/Liraglutide (IDegLira) in Subjects With Type 2 Diabetes Mellitus Using Two Different Titration Algorithms Status COMPLETED Phase PHASE3
NCT02284230 The Effect of Liraglutide in Patients With Prediabetes and Kidney Failure Status WITHDRAWN Phase PHASE2
NCT02255266 Long-Term Effectiveness of Liraglutide for Treatment of Type 2 Diabetes in Daily Practice Status COMPLETED Phase N/A
NCT02254291 A Trial Comparing the Safety and Efficacy of Semaglutide Once Weekly Versus Sitagliptin Once Daily in Japanese Subjects With Type 2 Diabetes Status COMPLETED Phase PHASE3
NCT02249910 Investigating the Influence of Oral Semaglutide on Pharmacokinetics of Metformin and Digoxin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02249871 Investigating the Influence of Omeprazole on the Pharmacokinetics of Oral Semaglutide in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02243098 Investigating the Influence of Semaglutide on the Pharmacokinetics of Single Doses of Atorvastatin and Digoxin in Healthy Subjects Status COMPLETED Phase PHASE1
NCT02241694 To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives Status COMPLETED Phase N/A
NCT02239146 Safety of rFXIII in Patients Following First Time Myocardial Revascularization Requiring Cardiopulmonary Bypass Status COMPLETED Phase PHASE1
NCT02235961 Investigate Safety, Tolerability and Pharmacokinetics for Single Doses of NNC9204-0530 Alone and in Combination With Liraglutide in Overweight to Obese But Otherwise Healthy Male Subjects Status COMPLETED Phase PHASE1
NCT02231684 Investigating the Pharmacokinetics of Subcutaneous Injections With 1 mg/mL, 3 mg/mL, and 10 mg/mL Semaglutide Strengths and the Absolute Bioavailability of Semaglutide Status COMPLETED Phase PHASE1
NCT02230631 A Survey on Hypoglycaemia Among Insulin-treated Patients With Diabetes Status COMPLETED Phase N/A
NCT02230618 Post Marketing Surveillance (PMS) Study of Ryzodeg™ (Insulin Degludec/Insulin Aspart) in Patients With Diabetes Mellitus in Routine Clinical Practice in India Status COMPLETED Phase N/A